In addition to IgG and IgM, which are commonly used in the serological assessment of EBV infection, IgA antibodies—particularly against EBNA1—may also hold diagnostic and prognostic value, as demonstrated in nasopharyngeal carcinoma and potentially other EBV-associated conditions [21]. The gene discussed is CD79A; the disease is Epstein-Barr virus infection.